| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.19 | 5e-05 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-05 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-05 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-05 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0004 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0005 |